{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:53:23Z","timestamp":1793051603550,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:00:00Z","timestamp":1589846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["17\/129\/02"],"award-info":[{"award-number":["17\/129\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Supervised cardio-pulmonary rehabilitation may be safe and beneficial for people with pulmonary hypertension (PH) in groups 1 (pulmonary arterial hypertension) and 4 (chronic thromboembolic disease), particularly as a hospital in-patient. It has not been tested in the most common PH groups; 2 (left heart disease), 3 (lung disease), or 5 (other disorders). Further it has not been evaluated in the UK National Health Service (NHS) out-patient setting, or with long-term follow-up. The aim of this randomised controlled trial (RCT) is to test the clinical and cost-effectiveness of a supervised exercise rehabilitation intervention with psychosocial support compared to best practice usual care for people with PH in the community\/outpatient setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This multi-centre, pragmatic, two-arm RCT with embedded process evaluation aims to recruit 352 clinically stable adults with PH (groups 1\u20135) and WHO functional class II-IV. Participants will be randomised to either the Supervised Pulmonary Hypertension Exercise Rehabilitation (SPHERe) intervention or control. The SPHERe intervention consists of 1) individual assessment and familiarisation sessions; 2) 8-week, twice-weekly, supervised out-patient exercise training; 3) psychosocial\/motivational support and education; 4) guided home exercise plan. The control intervention consists of best practice usual care with a single one-to-one practitioner appointment, and general advice on physical activity. Outcomes will be measured at baseline, 4 months (post-intervention) and 12\u2009months by researchers blinded to treatment allocation. The primary outcome is the incremental shuttle walk test at 4 months. Secondary outcomes include health-related quality of life (HRQoL), time to clinical worsening and health and social care use. A purposive sample of participants (<jats:italic>n<\/jats:italic>\u00a0=\u200920 intervention and <jats:italic>n<\/jats:italic>\u00a0=\u200920 control) and practitioners (<jats:italic>n<\/jats:italic>\u00a0=\u200920) will be interviewed to explore experiences of the trial, outcomes and interventions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The SPHERe study is the first multi-centre clinical RCT to assess the clinical and cost effectiveness of a supervised exercise rehabilitation intervention compared to usual care, delivered in the UK NHS, for people in all PH groups. Results will inform clinicians and commissioners as to whether or not supervised exercise rehabilitation is effective and should be routinely provided for people with PH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isrctn.com\/ISRCTN10608766\">ISRCTN no. 10608766<\/jats:ext-link>, prospectively registered on 18th March 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-020-01182-y","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T13:04:20Z","timestamp":1589893460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Supervised pulmonary hypertension exercise rehabilitation (SPHERe): study protocol for a multi-centre randomised controlled trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8963-9107","authenticated-orcid":false,"given":"Gordon","family":"McGregor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Lall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harbinder","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Seers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithwish","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Canaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J. C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bowater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Clift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,19]]},"reference":[{"key":"1182_CR1","doi-asserted-by":"publisher","first-page":"f2028","DOI":"10.1136\/bmj.f2028","volume":"346","author":"DG Kiely","year":"2013","unstructured":"Kiely DG, Elliot CA, Sabroe I, Condliffe R. Pulmonary hypertension: diagnosis and management. BMJ. 2013;346:f2028.","journal-title":"BMJ."},{"issue":"2","key":"1182_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/resp.13141","volume":"23","author":"DL Tran","year":"2018","unstructured":"Tran DL, Lau EMT, Celermajer DS, Davis GM, Cordina R. Pathophysiology of exercise intolerance in pulmonary arterial hypertension. Respirology. 2018;23(2):148\u201359.","journal-title":"Respirology."},{"key":"1182_CR3","first-page":"37","volume":"2016","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2015;2016:37.","journal-title":"Eur Heart J"},{"issue":"1","key":"1182_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12872-017-0674-3","volume":"17","author":"CD Vizza","year":"2017","unstructured":"Vizza CD, Jansa P, Teal S, Dombi T, Zhou D. Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial. BMC Cardiovasc Disord. 2017;17(1):239.","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"1182_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ccl.2016.04.011","volume":"34","author":"NH Kim","year":"2016","unstructured":"Kim NH. Group 4 pulmonary hypertension: chronic thromboembolic pulmonary hypertension: epidemiology, pathophysiology, and treatment. Cardiol Clin. 2016;34(3):435\u201341.","journal-title":"Cardiol Clin"},{"key":"1182_CR6","doi-asserted-by":"publisher","first-page":"j5492","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.","journal-title":"BMJ."},{"key":"1182_CR7","doi-asserted-by":"publisher","unstructured":"Fein DG, Zaidi AN, Sulica R. Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies. J Clin Med. 2016;5(9):75. https:\/\/doi.org\/10.3390\/jcm5090075.","DOI":"10.3390\/jcm5090075"},{"key":"1182_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-981-10-4304-8_10","volume":"1000","author":"AS Babu","year":"2017","unstructured":"Babu AS, Arena R, Morris NR. Evidence on exercise training in pulmonary hypertension. Adv Exp Med Biol. 2017;1000:153\u201372.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1182_CR9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/resp.13025","volume":"22","author":"JA Alison","year":"2017","unstructured":"Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, et al. Australian and New Zealand pulmonary rehabilitation guidelines. Respirology. 2017;22(4):800\u201319.","journal-title":"Respirology."},{"issue":"1","key":"1182_CR10","doi-asserted-by":"publisher","first-page":"e000400","DOI":"10.1136\/bmjsem-2018-000400","volume":"4","author":"G McGregor","year":"2018","unstructured":"McGregor G, Powell R, Finnegan S, Nichols S, Underwood M. Exercise rehabilitation programmes for pulmonary hypertension: a systematic review of intervention components and reporting quality. BMJ Open Sport Exerc Med. 2018;4(1):e000400.","journal-title":"BMJ Open Sport Exerc Med"},{"key":"1182_CR11","volume-title":"Quality standard (QS9) Heart failure in adults. Programme of cardiac Rehabilitation","author":"NICE","year":"2016","unstructured":"NICE. Quality standard (QS9) Heart failure in adults. Programme of cardiac Rehabilitation. https:\/\/www.nice.org.uk\/guidance\/qs9\/chapter\/Quality-statement-6-Programme-of-cardiac-rehabilitation. 2016."},{"issue":"Suppl 2","key":"1182_CR12","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2013-203808","volume":"68","author":"CE Bolton","year":"2013","unstructured":"Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68(Suppl 2):ii1\u201330.","journal-title":"Thorax"},{"key":"1182_CR13","first-page":"CD003793","volume":"2","author":"B McCarthy","year":"2015","unstructured":"McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.","journal-title":"Cochrane Database Syst Rev"},{"key":"1182_CR14","first-page":"CD011273","volume":"12","author":"L Anderson","year":"2014","unstructured":"Anderson L, Taylor RS. Cardiac rehabilitation for people with heart disease: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2014;12:CD011273.","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"1182_CR15","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1016\/j.jacc.2017.01.051","volume":"69","author":"M Guazzi","year":"2017","unstructured":"Guazzi M, Naeije R. Pulmonary hypertension in heart failure: pathophysiology, pathobiology, and emerging clinical perspectives. J Am Coll Cardiol. 2017;69(13):1718\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"1182_CR16","first-page":"CD011285","volume":"1","author":"NR Morris","year":"2017","unstructured":"Morris NR, Kermeen FD, Holland AE. Exercise-based rehabilitation programmes for pulmonary hypertension. Cochrane Database Syst Rev. 2017;1:CD011285.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1182_CR17","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1183\/09031936.00150314","volume":"44","author":"AE Holland","year":"2014","unstructured":"Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428\u201346.","journal-title":"Eur Respir J"},{"issue":"1","key":"1182_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.pcad.2015.11.005","volume":"59","author":"R Arena","year":"2016","unstructured":"Arena R, Lavie CJ, Borghi-Silva A, Daugherty J, Bond S, Phillips SA, et al. Exercise training in group 2 pulmonary hypertension: which intensity and what modality. Prog Cardiovasc Dis. 2016;59(1):87\u201394.","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"1182_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1183\/09031936.00123711","volume":"40","author":"E Grunig","year":"2012","unstructured":"Grunig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, et al. Safety and efficacy of exercise training in various forms of pulmonary hypertension. Eur Respir J. 2012;40(1):84\u201392.","journal-title":"Eur Respir J"},{"key":"1182_CR20","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ"},{"key":"1182_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2288-13-104","volume":"13","author":"SA Billingham","year":"2013","unstructured":"Billingham SA, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom clinical research network database. BMC Med Res Methodol. 2013;13:104.","journal-title":"BMC Med Res Methodol"},{"key":"1182_CR22","volume-title":"Guidelines for exercise testing and prescription","author":"ACSM","year":"2017","unstructured":"ACSM. Guidelines for exercise testing and prescription. 10th ed. Riverwoods: Lippincott Williams & Wilkins; 2017.","edition":"10"},{"key":"1182_CR23","first-page":"2013","volume-title":"American College of Sports Medicine\u2019s guide to clinical exercise testing and prescription","author":"M Whaley","year":"2013","unstructured":"Whaley M, Brubaker P, Otto R, Armstrong L. American College of Sports Medicine\u2019s guide to clinical exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 2013."},{"key":"1182_CR24","volume-title":"Standards for physical activity and exercise in the cardiac population","author":"ACPICR","year":"2015","unstructured":"ACPICR. Standards for physical activity and exercise in the cardiac population 2015. Available at: http:\/\/acpicr.com."},{"issue":"15","key":"1182_CR25","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1136\/heartjnl-2012-303460","volume":"99","author":"JP Buckley","year":"2013","unstructured":"Buckley JP, Furze G, Doherty P, Speck L, Connolly S, Hinton S, et al. BACPR scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation. Heart. 2013;99(15):1069\u201371.","journal-title":"Heart."},{"key":"1182_CR26","volume-title":"Borg's perceived exertion and pain scales","author":"G Borg","year":"1998","unstructured":"Borg G. Borg's perceived exertion and pain scales. Champaign: Human Kinetics; 1998."},{"issue":"16","key":"1182_CR27","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1161\/CIR.0000000000000483","volume":"135","author":"DE Forman","year":"2017","unstructured":"Forman DE, Arena R, Boxer R, Dolansky MA, Eng JJ, Fleg JL, et al. Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2017;135(16):e894\u2013918.","journal-title":"Circulation."},{"issue":"2","key":"1182_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1037\/0033-295X.84.2.191","volume":"84","author":"A Bandura","year":"1977","unstructured":"Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191\u2013215.","journal-title":"Psychol Rev"},{"key":"1182_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.","journal-title":"Implement Sci"},{"issue":"25 Suppl","key":"1182_CR30","doi-asserted-by":"publisher","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","volume":"62","author":"G Simonneau","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1182_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.healun.2017.04.008","volume":"36","author":"CG Billings","year":"2017","unstructured":"Billings CG, Hurdman JA, Condliffe R, Elliot CA, Smith IA, Austin M, et al. Incremental shuttle walk test distance and autonomic dysfunction predict survival in pulmonary arterial hypertension. J Heart Lung Transplant. 2017;36(8):871\u20139.","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"1182_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","volume":"15","author":"SP McKenna","year":"2006","unstructured":"McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J. The Cambridge pulmonary hypertension outcome review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res. 2006;15(1):103\u201315.","journal-title":"Qual Life Res"},{"issue":"10","key":"1182_CR33","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res"},{"issue":"5","key":"1182_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1159\/000445805","volume":"91","author":"G Somaini","year":"2016","unstructured":"Somaini G, Hasler ED, Saxer S, Huber LC, Lichtblau M, Speich R, et al. Prevalence of anxiety and depression in pulmonary hypertension and changes during therapy. Respiration. 2016;91(5):359\u201366.","journal-title":"Respiration."},{"issue":"10","key":"1182_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121\u20133.","journal-title":"Arch Neurol"},{"issue":"1","key":"1182_CR36","doi-asserted-by":"publisher","first-page":"e000263","DOI":"10.1136\/bmjresp-2017-000263","volume":"5","author":"J Yorke","year":"2018","unstructured":"Yorke J, Deaton C, Campbell M, McGowen L, Sephton P, Kiely DG, et al. Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study. BMJ Open Respir Res. 2018;5(1):e000263.","journal-title":"BMJ Open Respir Res"},{"issue":"13","key":"1182_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","volume":"114","author":"VV McLaughlin","year":"2006","unstructured":"McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006;114(13):1417\u201331.","journal-title":"Circulation."},{"issue":"5","key":"1182_CR38","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1378\/chest.12-3023","volume":"144","author":"AE Frost","year":"2013","unstructured":"Frost AE, Badesch DB, Miller DP, Benza RL, Meltzer LA, McGoon MD. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest. 2013;144(5):1521\u20139.","journal-title":"Chest."},{"issue":"15","key":"1182_CR39","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/sim.3115","volume":"27","author":"M Moerbeek","year":"2008","unstructured":"Moerbeek M, Wong WK. Sample size formulae for trials comparing group and individual treatments in a multilevel model. Stat Med. 2008;27(15):2850\u201364.","journal-title":"Stat Med"},{"key":"1182_CR40","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical research ed). 2010;340:c332.","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"1182_CR41","doi-asserted-by":"publisher","first-page":"e0147311","DOI":"10.1371\/journal.pone.0147311","volume":"11","author":"KL Mengersen","year":"2016","unstructured":"Mengersen KL, Drovandi CC, Robert CP, Pyne DB, Gore CJ. Bayesian estimation of small effects in exercise and sports science. PLoS One. 2016;11(4):e0147311.","journal-title":"PLoS One"},{"key":"1182_CR42","unstructured":"NICE. Guide to the methods of technology appraisal. Available at: https:\/\/www.nice.org.uk\/process\/pmg9\/chapter\/the-reference-case2013.."},{"key":"1182_CR43","volume-title":"Unit costs of health and social care 2019","author":"L Curtis","year":"2018","unstructured":"Curtis L, Burbs A. Unit costs of health and social care 2019. Canterbury: Personal Social Services Research Unit, University of Kent; 2018."},{"key":"1182_CR44","unstructured":"NHS Improvement. National Cost Collection for the NHS. Available at: https:\/\/improvement.nhs.uk\/resources\/national-cost-collection\/2020.."},{"key":"1182_CR45","unstructured":"NICE. Position statement on use of the EQ-5D-5L value set for England. Available at: https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/technology-appraisal-guidance\/eq-5d-5l2019."},{"key":"1182_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"1182_CR47","doi-asserted-by":"publisher","first-page":"e003555","DOI":"10.1136\/bmjopen-2013-003555","volume":"3","author":"T Mars","year":"2013","unstructured":"Mars T, Ellard D, Carnes D, Homer K, Underwood M, Taylor SJ. Fidelity in complex behaviour change interventions: a standardised approach to evaluate intervention integrity. BMJ Open. 2013;3(11):e003555.","journal-title":"BMJ Open"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01182-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-020-01182-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01182-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:02:12Z","timestamp":1721476932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01182-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["1182"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01182-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was received via the Integrated Research Application System (261218) and the West Midlands Coventry & Warwickshire Research Ethics Committee (19\/WM\/0155) and Health Research Authority on 13th July 2019. Each trial site will confirm local NHS Trust Research & Development (R&D) department capacity and capability prior to commencing recruitment. All participants will provide written informed consent prior to participating in the study. UHCW NHS Trust are the sponsor for the trial. The trial will be conducted in accordance with the declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}